Recently, the China National Intellectual Property Administration (CNIPA), together with Danish Patent and Trademark Office (DPTO) and the Embassy of the Kingdom of Denmark to China, held a bioscience and health IP seminar in both online and offline way. The event was addressed by CNIPA Commissioner Shen Changyu, Danish Ambassador H.E. Thomas Østrup Møller and DPTO Director General Sune Stampe Sørensen.
Shen briefed on China's experience and practice in refining IP protection norms and boosting innovative development of the pharmaceutical industry. He proposed countries should enhance cooperation, under the new circumstances, take on challenges together and facilitate IP protection to better serve innovations. China is willing to expand cooperation range with Danish partners to advance win-win IP cooperation, contribute to development of the two countries and wellbeing of the two peoples.
Møller said the seminar functions as a platform for both sides to compare notes and share experience in IP issues. CNIPA and DPTO have been keeping a close tie for many years with palpable rewards reaped.
Sørensen noted IP protection is crucial for introduction of investment and company innovation. The two sides are expected to know each other better with the seminar, which will eventually benefit companies of the two countries.
At the seminar, CNIPA and DPTO experts spoke on IP strategies of the two countries, the fourth amendment of the Patent Law, early resolution mechanism for pharmaceutical patent disputes, patent invalidation and other subjects. Industry representatives from the two countries also shared wisdom with the experts on issues of their interest.(Translated from CNIPA Website Chinese Version)